FindTrial
Sign In

EFFECT OF YOGANIDRA IN HYPERTENSION

EFFECT OF YOGANIDRA AS AN ADD ON THERAPY VERSUS STANDARD NON PHARMACOLOGICAL INTERVENTIONS IN CHANGE IN BLOOD PRESSURE IN SUBJECTS OF ESSENTIAL HYPERTENSION: ASSESSOR BLIND RANDOMISED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050669
Enrollment
60
Registered
2023-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: YOGANIDRA: Yoganidra means sleeping consciously which systematically induces complete physical, mental and emotional relaxation. Frequency: Daily Duration: 3 months Control Intervention

Sponsors

DR ANANYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 18-60 diagnosed with essential hypertension (Stage I and Stage II) 2.Ready to adhere to study specified procedures.

Exclusion criteria

Exclusion criteria: 1.Patients with co- morbidities like DM/ CKD/CVA/CAD/COPD 2.Patients with secondary causes of hypertension 3.Pregnant or lactating females 4.Patients with diagnosed sleep disorder, major psychiatric disorder or cognitive disorder Patients not giving informed written consent

Design outcomes

Primary

MeasureTime frame
Primary outcome for this study will be reduction in blood pressureTimepoint: Total duration: 3 months Follow up: At the end of 1st, 2nd and 3rd months—

Secondary

MeasureTime frame
The Secondary Outcomes will include changes in Anthropometric Measurements: Body Mass Index and waist hip circumference, quality of sleep assessed by PSQI questionnaire and stress levels using PSS questionnaireTimepoint: Total duration: 3 months Follow up at 1st, 2nd and 3rd month—

Countries

India

Contacts

Public ContactDR ANANYA

AIIMS RISHIKESH

anshupathania27@gmail.com08126021556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026